Clinical Trial Update: Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on cisplatin-based chemoradiation with or without cetuximab for locoregionally advanced head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)

Snippet

Sponsor: Theagenio Cancer Hospital | Conditions: Head and Neck Neoplasms, AJCC Stage III/IV | Phase 2 | Status: UNKNOWN